MedCity News March 1, 2022
Sara Rogers

Leveraging a precision prescribing platform with embedded genomic analysis will help physicians improve care and reduce costs by providing valuable information to inform mental health medication choices that can deliver treatment success for their patients from the start.

The Covid-19 pandemic has impacted the quality of care, access to healthcare providers, and driven a greater demand for mental health professionals than ever before in modern medicine. To slow the spread of Covid-19 and address the demand for acute care due to the number of Covid-19 cases, maintenance and surveillance care overall was delayed or abandoned between March 2020 and March 2021 leading to the current backlog of undertreated patients.

Mental health has a surge in need

The greatest Covid-19 associated...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Mental Health, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Public Health / COVID
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
The Future of Behavioral Health Delivery
Fixing the Growing Payer-Provider Divide in Behavioral Health
Workers Feel “Stuck,” Under-Insured, Financially Stressed, and Neglecting Mental Health
Franciscan Health to convert hospital to behavioral health facility

Share This Article